Tops & Flops Stocks
Security ▼ | Change (%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Zosano Pharma Corp. | - | - | - | - | - | - | - |
Zogenix Inc. | - | - | - | - | - | - | - |
Ziopharm Oncology | 11.930% | - | - | - | - | - | - |
Zealand Pharma A/s | -1.790% | 1.908% | 0.513% | 238.617% | 131.755% | 379.592% | - |
XOMA Corp. | -3.050% | 0.000% | 18.018% | 104.688% | 55.030% | 7.377% | 63.730% |
Xeris Biopharma Holdings Inc. | -2.130% | -9.677% | 3.704% | 6.909% | 8.889% | 1.379% | - |
Xenon Pharmaceuticals Inc. | -0.540% | -1.093% | -9.045% | 2.260% | -10.837% | - | - |
XBiotech Inc | -7.020% | -1.724% | -10.236% | 26.667% | 61.017% | -57.239% | -24.222% |
X4 Pharmaceuticals, Inc. | -2.910% | 1.282% | -20.503% | -47.333% | -18.974% | - | - |
Wenzhou Kangning Hospital Co Ltd | 3.850% | 6.849% | 9.091% | 11.429% | 6.849% | -47.651% | -45.550% |
WAVE Life Sciences Ltd | 0.000% | -4.762% | -12.281% | 23.153% | 9.170% | -6.821% | - |
Voyager Therapeutics Inc | -5.400% | -5.740% | -29.584% | -39.734% | -28.742% | 86.594% | -63.709% |
Vivani Medical Inc. | -4.350% | -2.542% | 7.477% | 27.778% | 22.340% | -87.714% | -92.886% |
Vitrolife AB | 0.000% | 10.142% | 11.614% | 71.835% | 22.435% | - | - |
Vita 34 AG | -1.680% | 6.250% | 6.726% | 9.425% | -9.160% | -68.889% | -60.333% |
Virtus Health Ltd | - | - | - | - | - | - | - |
Virbac S.A. | 0.740% | -0.444% | -0.148% | 24.170% | -6.267% | -4.944% | 99.585% |
Viracta Therapeutics Inc. | 10.640% | -3.590% | -54.146% | -86.176% | -61.943% | -97.481% | -99.333% |
Viking Therapeutics Inc | -0.110% | -3.643% | 8.848% | 292.870% | 202.545% | 823.534% | 765.227% |
ViewRay Inc | 2400.000% | - | - | - | - | - | - |
Vericel Corp. | -3.900% | -3.347% | 7.944% | 52.980% | 42.593% | -1.282% | 207.058% |
Verastem Inc. | -1.820% | -5.983% | -4.348% | 133.918% | -70.861% | -92.098% | -84.037% |
Veracyte Inc. | -3.520% | 0.000% | 43.434% | 19.328% | 10.078% | -33.333% | 19.028% |
Veloxis Pharmaceuticals As | - | - | - | - | - | - | - |
Vectura plc | - | - | - | - | - | - | - |